The tale of two organs: Addressing menopause stigma
Should we start treating menopause as a disease condition? In our view, it's a chronic disease condition that can go beyond two decades for some women, resulting in silent suffering.
Evernow CEO and founder shares why she started a healthcare startup focused on women over 40
In response to emailed questions, Alicia Jackson talked about her healthcare background and how the healthcare startup is responding to a shifting legal landscape for women's health following the overturning of Roe v. Wade by the U.S. Supreme Court.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Lisa Health launches digital menopause app with Mayo Clinic
Digital health startup Lisa Health recently launched Midday, an app it co-developed with Mayo Clinic to help women navigate menopause. The Oakland-based company also announced the close of its $2.5 million oversubscribed seed round led by Radical Ventures.
HerMD raises $10M to expand women’s sexual health, menopause services
The company currently operates two centers, one in Cincinnati and the other in Crescent Springs, Kentucky. The Series A funding round led by JAZZ Venture Partners will allow the company to open new locations as well as offering virtual care.
Why Elektra’s founders decided to tackle a ‘complex and poorly understood’ area of women’s health
Founders Alessandra Henderson and Jannine Versi set out to build a digital health platform for people who are going through menopause. The New York-based startup recently raised $3.75 million in funding.
Startup genneve debuts menopause telehealth platform
The Seattle-based company's platform is initially available in four states: California, Georgia, New Jersey and Washington.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
UK-based KaNDy Therapeutics raises $32.5 million Series C round, led by US firm
Longitude Capital leads round worth £25 million, which KaNDy will use to advance its non-hormonal menopause drug into Phase IIb clinical trial this year.
Studies speak volumes about brain changes and cognition in women
BOSTON (IMNG) – Women who complain about cognitive problems after menopause might have increases rather than decreases in volume of certain brain regions, reported investigators at the Alzheimer’s Association International Conference 2013. Brain imaging studies of 48 women in the early years of menopause showed that those with subjective cognitive complaints had significantly greater volumes […]